A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

Clinical trial NCT06953583 · RECRUITING

Trial details

NCT number: NCT06953583
Sponsor: Biogen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Friedreich Ataxia

Start date: 2025-06-09
Primary completion: 2027-11-16
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.